Lonza | LONN - Ebitda


Lonza reported CHF1.01B in EBITDA for its fiscal semester ending in December of 2025.





Ebitda Change Date
Akzo Nobel EUR 388M 10M Sep/2026
Alcon AG USD 795M 478M Mar/2026
Almirall EUR 114.07M 60.37M Dec/2025
AstraZeneca USD 7.46B 2.3B Sep/2026
BASF EUR 1.64B 806M Sep/2026
Bayer EUR 1.62B 529M Sep/2026
Beiersdorf EUR 926M 58M Jun/2026
Covestro EUR 117M 125M Dec/2025
Demant DKK 2.8B 47M Jun/2026
Fresenius EUR 912M 76M Sep/2026
Fresenius Medical Care EUR 817M 26.66M Sep/2026
Geberit CHF 177.6M 58.4M Dec/2025
Genmab DKK 401M 186M Jun/2026
Givaudan CHF 778M 195M Dec/2025
GlaxoSmithKline GBP 3.51B 734M Jun/2026
GN Store Nord DKK 354M 2M Sep/2026
Hikma Pharmaceutical USD 369M 84M Dec/2024
Johnson Matthey GBP 325M 52M Jun/2024
Merck EUR 1.6B 69M Jun/2026
Novartis USD 8.62B 2.14B Sep/2026
Philips EUR 772M 138M Sep/2026
Roche Holding CHF 13.43B 744M Jun/2026
Sanofi EUR 5.79B 2.1B Sep/2026
Sika AG CHF 994.3M 76.1M Dec/2025
Smith & Nephew USD 796M 139M Dec/2025
Solvay EUR 173M 14M Sep/2026
UCB EUR 1.6B 570M Dec/2025